Fisher Asset Management LLC Has $195.09 Million Stake in iShares U.S. Pharmaceuticals ETF $IHE

Fisher Asset Management LLC reduced its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 5.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,976,691 shares of the company’s stock after selling 166,258 shares during the quarter. Fisher Asset Management LLC owned 36.30% of iShares U.S. Pharmaceuticals ETF worth $195,092,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of IHE. JPMorgan Chase & Co. grew its position in shares of iShares U.S. Pharmaceuticals ETF by 781.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 110,936 shares of the company’s stock valued at $7,271,000 after purchasing an additional 98,352 shares during the period. Cetera Investment Advisers boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 12.8% in the second quarter. Cetera Investment Advisers now owns 13,220 shares of the company’s stock valued at $866,000 after buying an additional 1,505 shares during the period. Envestnet Asset Management Inc. boosted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 2.8% in the second quarter. Envestnet Asset Management Inc. now owns 8,633 shares of the company’s stock valued at $566,000 after buying an additional 238 shares during the period. Boothe Investment Group Inc. bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter worth $602,000. Finally, Harbor Asset Planning Inc. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the second quarter worth $27,000.

iShares U.S. Pharmaceuticals ETF Trading Down 1.4%

IHE opened at $84.18 on Tuesday. The stock has a market capitalization of $677.65 million, a P/E ratio of 17.75 and a beta of 0.54. iShares U.S. Pharmaceuticals ETF has a 12 month low of $58.97 and a 12 month high of $86.17. The firm’s fifty day simple moving average is $76.85 and its 200 day simple moving average is $70.90.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.